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Abstract As a result of Myc-dependent transcription of the
LDH-A gene, Myc-transformed cells (Rat1-Myc) exhibit
increased lactate production rates (LPR) even under aerobic
conditions (the Warburg effect). Recently, the increased
susceptibility to stress-induced apoptosis associated with Myc
transfection has been linked to the overexpression of the LDH-A
gene. In this report we demonstrate that the overexpression of the
anti-apoptotic protein Bcl32 in Rat1-Myc cells (Rat1-Myc-
Bcl32) reduces the molar ratio of lactate production to glucose
consumption (YL=G). The Bcl32 induced reduction in YL=G may
be associated with reduced expression of the LDH-A gene, or a
decrease in LDH-A activity. Stimulation of apoptosis by
staurosporine, a protein kinase C inhibitor, reduces the LPR in
Rat1-Myc cells in a dose-dependent manner. The staurosporine
effect on the LPR is rapid and precedes the execution phase of
apoptosis as defined by caspase activation and PARP cleavage.
This effect on LPR is completely blocked by Bcl-2 over-
expression. Serum starvation alone does not affect the LPR of
Rat1-Myc or Rat1-Myc-Bcl-2 cells ; however, the effect of
staurosporine on the LPR of Rat1-Myc cells is potentiated by
serum starvation. These data demonstrate that Bcl-2 over-
expression reduces the YL=G in Rat1-Myc cells, perhaps via a
reduction in the activity or expression of the LDH-A gene, and
this reduction may desensitize cells to some pro-apoptotic
stimuli. The reduction in LPR in response to staurosporine
may be an early step in the induction of apoptosis in Rat1-Myc
cells. By abolishing the reduction in LPR, Bcl-2 may protect
Rat1-Myc cells from staurosporine-induced apoptosis. More-
over, the lack of effect by serum starvation on the LPR supports
a model in which serum starvation induces apoptosis through a
pathway distinct from that of the staurosporine and glucose-
dependent apoptotic pathway(s) in Myc-transformed cells.
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1. Introduction
Alterations in glucose metabolism have been shown to
cause apoptosis in Myc-transformed cells by a glucose-de-
pendent apoptotic pathway [1]. It has been hypothesized
that this glucose-dependent apoptotic pathway is speci¢cally
regulated by c-Myc since apoptosis caused by glucose starva-
tion or exposure to 2-deoxyglucose does not occur in the
absence of c-Myc expression [1,2]. Myc transfection has
been shown to upregulate expression of the lactate dehydro-
genase (LDH-A) gene, and ectopic expression of LDH-A is
su⁄cient to sensitize non-Myc-transfected cells to apoptosis
induced by glucose starvation or 2-deoxyglucose exposure
[1,2]. Bcl-2 overexpression protects Myc-transfected cells
from apoptosis induced by glucose starvation, and abolishes
the sensitization induced by overexpression of LDH-A [1]. The
mechanism by which overexpression of LDH-A and glucose
deprivation induce apoptosis remains to be elucidated. It has
been suggested that a reduction in constitutive generation of
NAD and lactate by LDH-A and a decrease in regeneration
of NADH by the inhibition of glycolysis may be involved [1].
Moreover, changes in NAD and NADH levels may trigger
apoptosis by altering the cellular redox state [1]. The mecha-
nism by which Bcl-2 inhibits apoptosis induced by glucose
starvation and 2-deoxyglucose exposure is still unknown.
It has been shown that an early event which precedes the
proteolytic phase of apoptosis is the release of cytochrome c
from mitochondria, a process that is blocked by Bcl-2 or Bcl-
XL expression [3^5]. It is, however, unclear whether changes
in cellular metabolism (perhaps related to mitochondrial dis-
ruption) have a causal e¡ect or are a consequence of apopto-
sis induction [6]. We reasoned that if the release of cyto-
chrome c precedes caspase activation, then metabolic
changes related to the disruption of oxidative phosphorylation
and perhaps other metabolic pathways might also be observed
prior to the onset of cell killing.
In this paper, we describe the e¡ects of staurosporine and/
or serum starvation on the LPR of Myc-transformed cells. We
also describe the e¡ects of Bcl-2 overexpression on glucose
metabolism as well as the response of Myc-transformed cells
to pro-apoptotic stimuli. Our results demonstrate that Bcl-2
overexpression alters glucose metabolism and reduces the ra-
tio of lactate production to glucose utilization (denoted YL=G)
in Rat1-Myc cells under aerobic conditions, that reduction in
the LPR is an early event which occurs prior to caspase acti-
vation, and that this e¡ect is completely abolished by over-
expression of Bcl-2. Serum starvation alone does not a¡ect the
LPR, but potentiates the e¡ect of staurosporine on the LPR
of Rat1-Myc cells.
2. Materials and methods
2.1. Cell lines and culture conditions
Rat1-Myc and Rat1-Myc-Bcl-2 (passage numbers 10^30) cells were
grown in DMEM (Gibco) supplemented with glucose (to a ¢nal con-
centration of 20 mM), 10% (v/v) fetal bovine serum (FBS) (Gibco),
100 U/ml penicillin and 100 Wg/ml streptomycin (Sigma). The culture
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medium was replaced daily and cell cultures were split 1:50 every
4 days and replated. On the day of the experiment the medium was
aspirated from the £asks and equal volumes of the desired media
without or with staurosporine (Sigma) were added to the cells. All
the media used in these experiments (including controls) contained
0.1% (v/v) DMSO (added as a vehicle for staurosporine). Samples
were removed at various times (depicted in the ¢gures) for glucose
and lactate concentration measurements. Glucose and lactate concen-
trations were measured with standard enzymatic assays performed
with an Ektachem DT-60 Analyzer (Eastman Kodak, NY).
2.2. Western analysis for PARP cleavage
On each 60 mm plate, Rat1-Myc cells were washed once with ice-
cold PBS and scraped into 1 ml of PBS. Cell pellets were collected by
pulse centrifugation and resuspended into 200 Wl of ice-cold PBS,
followed by the addition of 200 Wl of 2USDS-PAGE gel loading
bu¡er. Cellular DNA was sheared by sonication on ice prior to elec-
trophoresis. Equal amounts of protein lysates were resolved on a 10%
SDS-PAGE gel, transferred to nitrocellulose, and probed with anti-
PARP antibody (Biomol, 1:1000 dilution) and horseradish peroxi-
dase-conjugated donkey anti-rabbit IgG antibody (Amersham,
1:5000 dilution). Immunostained protein was subsequently visualized
via enhanced chemiluminescence (Amersham).
2.3. Statistics
Results are expressed as means þ standard deviations, and are based
on multiple independent measurements (n). Statistical signi¢cance was
determined by Student’s t-test.
3. Results
3.1. Myc transfection increases YL=G in Rat1 cells, and Bcl-2
overexpression reduces the YL=G in Rat1-Myc cells
Myc transfection has been shown to upregulate the LDH-A
gene [1], resulting in an increase in LDH-A activity that cor-
relates with an increase in the lactate production to glucose
consumption molar ratio (YL=G) under aerobic conditions [2].
In agreement with the observations of Shim and co-workers
[2], we observed a shift in the YL=G of Rat1 ¢broblasts which
had been transformed by Myc transfection and grown under
aerobic conditions (Table 1). Myc transfection increased the
YL=G of Rat1 cells by 50%, from 1.01 þ 0.11 to 1.53 þ 0.10
(n = 8). The overexpression of Bcl-2 in Rat1-Myc cells caused
a reduction in YL=G from 1.53 þ 0.10 to 1.29 þ 0.06 (n = 8), a
16% change that was statistically signi¢cant (P6 0.001). Myc
transfection increased the speci¢c LPR and glucose consump-
tion rate (GCR) of Rat1 cells, and Bcl-2 overexpression re-
duced both the speci¢c GCR and LPR of Rat1-Myc cells. The
GCR and LPR of Bcl-2 overexpressing cells were, however,
signi¢cantly higher than those of Rat1 cells (data not shown).
The reduction in YL=G caused by Bcl-2 overexpression sug-
gests that Bcl-2 may directly alter LDH-A gene expression,
or reduce LDH-A enzymatic activity. Assuming that an in-
crease in the LDH-A expression or LDH-A activity sensitizes
cells to pro-apoptotic stimuli [1], it can be argued that a de-
crease in LDH-A activity introduced by overexpression of
Bcl-2 may desensitize cells and thereby protect them from
some pro-apoptotic stimuli. This e¡ect on LDH-A may ex-
plain how Bcl-2 protects Myc-transformed cells from glucose-
dependent apoptosis.
3.2. E¡ects of serum starvation and/or staurosporine on LPR in
Rat1-Myc and Rat1-Myc-Bcl-2 cells
Exposure of Rat1-Myc cells to staurosporine reduced LPR
in a dose-dependent manner (Fig. 1). For the data presented
in Fig. 1, the LPR was calculated based on the increase in
lactate concentration with time over a period of 8 h. The
increase in lactate with time was highly linear over the 0^8
h time interval for both the control and staurosporine-treated
cells. The slope of the straight line in staurosporine-treated
cells was always lower compared to control cells. The above
observations suggest that the e¡ect of staurosporine on LPR
is rapid, and that shortly after exposure, staurosporine-treated
cells produce lactate at a constant and lower rate than the
control cells. It is important to note that in our experimental
system the reduction in LPR must occur well before a reduc-
tion in the lactate concentration in the incubation media is
observed. In the data shown in Fig. 2c, the earliest time point
for which a statistically signi¢cant di¡erence in lactate con-
centration was observed in staurosporine-treated versus con-
trol cells was after 3 h of exposure. The earliest time point for
which such a di¡erence was observed throughout our experi-
ments was after 30 min of exposure.
Serum starvation had no e¡ect on LPR of Rat1-Myc cells
as calculated from the slopes of the curves (Fig. 2a). Similar
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Table 1
E¡ects of Myc transfection and Bcl-2 overexpression on the lactate
production to glucose consumption molar ratio (YL=G)
Cell line YL=G (n)
Rat1 1.01 þ 0.11 (8)
Rat1-Myc 1.53 þ 0.10* (8)
Rat1-Myc-Bcl-2 1.29 þ 0.06*; (8)
Glucose consumption rates (GCR) and LPR were calculated from
slopes of the plots of glucose or lactate concentration versus time as
shown in Fig. 2. Values represent means þ S.D. based on independent
measurements (n) indicated in parentheses.
*Statistically signi¢cant di¡erence from the YL=G of Rat1 cells and
statistically signi¢cant di¡erence between the YL=G of Rat1-Myc and
Rat1-Myc-Bcl-2 (P6 0.001).
Fig. 1. E¡ects of staurosporine on the lactate production rate
(LPR) of Rat1-Myc cells incubated in serum-free DMEM. Identi-
cally seeded duplicate monolayer £asks were exposed for 8 h to se-
rum-free DMEM containing 0.00, 0.25, 0.50, 1.00 and 2.00 WM
staurosporine. For controls (no staurosporine), and cells exposed to
1 WM staurosporine, four additional £asks were used, bringing the
number of independent measurements to n = 6 (n is indicated in pa-
rentheses for each point). Media samples were removed from each
£ask at time zero and approximately every 2 h thereafter for lactate
concentration measurements. LPR was calculated from the slope of
the plot of lactate concentration versus time as shown in Fig. 2.
For each point, error bars represent the standard deviation based
on the number of independent measurements (n) indicated in paren-
theses. Where not seen, error bars are within the marker.
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results were obtained for Rat1-Myc-Bcl-2 cells (data not
shown). A staurosporine-mediated reduction in LPR was ob-
served in cultures incubated in serum-supplemented media
(Fig. 2b), and this e¡ect was further potentiated in serum-
free media (Fig. 2c, Table 2). It is not clear from these experi-
ments whether serum starvation potentiated the e¡ect of
staurosporine on the LPR synergistically, or whether serum
attenuated the e¡ect by reducing the bioavailability of stauro-
sporine through serum protein binding.
Di¡erences in the e¡ect of staurosporine on LPR of Rat1-
Myc (sensitive) and Rat1-Myc-Bcl-2 (resistant) cells are pre-
sented in Fig. 3a,b. There was no reduction in the LPR in
Rat1-Myc-Bcl-2 cells incubated in the presence of 1 WM
staurosporine, in contrast to the substantial reduction ob-
served in Rat1-Myc cells (Figs. 1 and 3b, Table 2).
Exposure of both Rat1-Myc and Rat1-Myc-Bcl-2 cells to
staurosporine caused a signi¢cant change in cellular morphol-
ogy (rounding-up) which was not observed in untreated cells.
No cell detachment was observed after a 4 h treatment with
staurosporine. The change in morphology is unrelated to the
e¡ect on the LPR since it was also observed in cells over-
expressing Bcl-2 (data not shown).
3.3. Staurosporine-mediated decrease in lactate production
precedes onset of PARP cleavage
At the onset of apoptosis, caspases become activated by an
autocatalytic event coupled to cytochrome c release from the
mitochondria and formation of a complex with APAF-1 [7,8].
Activated caspases play a critical role in ensuring apoptosis-
associated morphological changes [9^12]. Cleavage of PARP
is absolutely dependent on caspase activation, and is a hall-
mark of apoptosis [13]. While many metabolic changes are
associated with apoptosis [6], it is still unclear whether these
changes are the outcome of induction of apoptosis (especially
alterations in mitochondrial function), or whether they serve
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Fig. 3. E¡ect of staurosporine on lactate production in Rat1-Myc
and Rat1-Myc-Bcl-2 monolayers incubated in serum-free media.
Time-dependent lactate production in Rat1-Myc (a) and Rat1-Myc-
Bcl-2 (b) monolayers incubated in serum-free DMEM in the absence
(3,3), or presence (3,+) of 1 WM staurosporine. Error bars repre-
sent the standard deviation from the mean measurement performed
on identically seeded quadruplicate £asks (n = 4). Where not seen,
error bars are within the marker. The lactate production rate is cal-
culated from the slope of the line.
Fig. 2. Lactate production of Rat1-Myc monolayers incubated in se-
rum-free, and serum containing (10% v/v) DMEM media in the
presence (1 WM) or absence of staurosporine. Lactate concentration
pro¢les in £asks incubated in: (a) serum-free (3,3) and serum-con-
taining (+,3) DMEM in the absence of staurosporine; (b) serum-
containing DMEM in the absence (+,3) or presence (+,+) of 1 WM
staurosporine; (c) serum-free DMEM in the absence (3,3), or pres-
ence (3,+) of 1 WM staurosporine. Error bars represent the stand-
ard deviation from the mean measurement performed on identically
seeded duplicate £asks (n = 2). Where not seen, error bars are within
the marker. The slope of the lines re£ects the lactate production
rate (per £ask). The higher lactate concentration at time zero in cul-
tures incubated in serum-containing media re£ects the presence of
lactate in serum.
Table 2
Staurosporine e¡ects on lactate production of Rat1-Myc cells incu-
bated in serum-free or serum containing media
Serum Staurosporine Lactate production rate
% of control (n)
+ 3 100.0 þ 4.1 (6)
3 3 98.4 þ 3.1 (6)
+ 1 WM 83.4 þ 1.8* (6)
3 1 WM 61.7 þ 2.1*; (6)
Values represent means þ S.D. based on the number of independent
measurements (n) indicated in parentheses.
*Statistically signi¢cant di¡erence from the control, statistically sig-
ni¢cant di¡erence between the rates measured from £asks containing
cells incubated in 1 WM staurosporine in either the absence or pres-
ence of serum (P6 0.001).
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as signals that promote apoptosis [14^16]. To determine the
order of events at the onset of apoptosis, the cleavage of
PARP was examined in Rat1-Myc cells at di¡erent time peri-
ods following initiation by various apoptotic stimuli. In both
staurosporine-treated and serum-starved cells, PARP cleavage
was observed at 20 h but not at 8 h following stimulation
(Fig. 4). Furthermore, in a series of experiments with Rat1-
Myc cells, the release of cytochrome c was not observed at 4
h, but was detectable after 8 h exposure to 1 WM staurospor-
ine (data not shown). The combination of staurosporine and
serum starvation induced both PARP cleavage and degrada-
tion (Fig. 4, lane 10). Nevertheless, PARP cleavage still oc-
curred at a late time point and not prior to 8 h following
stimulation. No PARP cleavage was observed in staurospor-
ine treated Rat1-Myc-Bcl-2 cells, even after 20 h of exposure
(data not shown). Since the e¡ect of staurosporine on LPR is
rapid (i.e. it must have been initiated prior to 30 min of ex-
posure, see previous discussion), precedes cytochrome c re-
lease and the onset of PARP cleavage, the reduction of lactate
production by staurosporine could not be a consequence of
apoptosis. Furthermore, the staurosporine-mediated decrease
in lactate production was completely blocked in Rat1-Myc
cells overexpressing the anti-apoptotic gene Bcl-2 (Table 3)
suggesting that the metabolic pathway for lactate production
might be involved in early signaling events that would precede
the onset of apoptosis.
4. Discussion
It has been demonstrated that Myc transfection upregulates
the LDH-A gene, LDH-A activity, and increases the lactate
production to glucose consumption molar ratio (YL=G) in
Rat1 cells [1,2]. Myc-transformation has been associated
with an increased susceptibility to stress-induced apoptosis,
which has been recently linked to the overexpression of the
LDH-A gene [1]. Overexpression of the anti-apoptotic gene
Bcl-2 has been shown to protect Myc-transformed cells from
stress-induced apoptosis [1,2]. The mechanism by which Bcl-2
protects cells from apoptosis is largely unknown and the sub-
ject of intense investigation. Our observation that overexpres-
sion of the anti-apoptotic protein Bcl-2 in Rat1-Myc cells
reduces the YL=G is consistent with a reduction in the expres-
sion of the LDH-A gene or a reduction in LDH-A activity.
Based on a recent report demonstrating that an increase in
LDH-A expression or LDH-A activity sensitizes cells to pro-
apoptotic stimuli [1], it can be argued that a reduction in
LDH-A expression and/or LDH-A activity may ‘desensitize’
Rat1-Myc cells to such stimuli. Such a reduction caused by
overexpression of Bcl-2, may partly explain its ability to pro-
tect Myc-transformed cells from glucose-dependent apoptosis.
It is not clear from our results whether the entire population
of cells that are exposed to staurosporine reduce their LPR by
40%, or whether cells committed to apoptosis (40% of total
cells) completely stop lactate production. Either scenario
would generate the same e¡ect on LPR as observed here. It
is worth noting that in a study with a di¡erent cell line (HT-29
human colon adenocarcinoma), approximately 40% of cells
underwent apoptosis upon exposure to 1 WM staurosporine
for 48 h [17].
Our results demonstrate a clear e¡ect of staurosporine on
the LPR of Rat1-Myc cells. The e¡ect of staurosporine on
LPR was rapid and preceded the onset of the execution phase
of apoptosis as established by measuring PARP cleavage. The
above observations are consistent with the suggestion that
metabolic changes may be early signaling events, and may
be responsible for generating a signaling cascade which trig-
gers the execution phase of apoptosis. This does not imply
that other metabolic changes cannot be the consequence of
apoptosis after the onset of PARP cleavage.
One may hypothesize that the LPR may be an important
determinant in the signaling of staurosporine-induced apop-
tosis. This hypothesis is consistent with a model in which
changes in glycolytic £ux through LDH-A that result in stau-
rosporine-induced apoptosis may be identical or share com-
mon signaling intermediates with the recently described glu-
cose-dependent apoptotic pathway [1]. The fact that
overexpression of Bcl-2 blocks both the reduction in LPR
and apoptosis, suggests that the anti-apoptotic e¡ect of Bcl-
2 may be mediated via modulation of the LPR. It is unlikely
that di¡erences in the e¡ect of staurosporine are related to the
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Fig. 4. PARP cleavage in staurosporine-treated or serum-starved
Rat1-Myc Cells. Subcon£uent Rat1-Myc cells were treated with
staurosporine (1.0 WM), serum starvation (0.1% DMEM) or the
combination of staurosporine plus serum starvation. Cells were col-
lected and lysed at di¡erent periods of time (0^20 h). Cell lysates
were separated on 10% SDS-PAGE gel, and Western blot was per-
formed as described in Section 2. The arrows indicated the 116 kDa
PARP precursor and 87 kDa cleavage product.
Table 3
E¡ect of staurosporine on lactate production in Rat1-Myc and Rat1-Myc-Bcl-2 monolayers incubated in serum-free media
Cell line Staurosporine Lactate production rate
% of control (n)
Rat1-Myc 3 100.0 þ 2.1 (4)
+ 64.5 þ 1.7* (4)
Rat1-Myc-Bcl-2 3 100.0 þ 0.2 (4)
+ 104.2 þ 5.7NS (4)
Conditions: monolayers incubated in serum-free DMEM in the absence (3) or presence (+) of 1 WM staurosporine. Values represent means þ S.D.
based on the number of independent measurements (n) indicated in parentheses.
*Statistically signi¢cant di¡erence from the control (P6 0.001); NS = not signi¢cant.
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multiple drug resistance (MDR) phenotype since both Rat1-
Myc and Rat1-Myc-Bcl-2 cell lines express equal levels of P-
glycoprotein (data not shown). Our data also suggest that
although overexpression of Bcl-2 blocks staurosporine-medi-
ated reduction in LPR, it does not block other metabolic
e¡ects (manuscript in preparation).
Serum starvation alone had no e¡ect on the LPR of Rat1-
Myc cells despite the fact that it could induce apoptosis. This
observation is consistent with the hypothesis that serum star-
vation induces apoptosis via a mechanism that is independent
of the glucose-dependent pathway [1]. The e¡ect of stauro-
sporine on the LPR, however, was potentiated by the absence
of serum from the incubation media. Further work is required
to establish whether serum starvation potentiates the e¡ect of
staurosporine synergistically or whether serum reduces the
bioavailability of staurosporine via protein binding.
In summary, the results presented in this paper demonstrate
that staurosporine a¡ects the LPR of Rat1-Myc cells prior to
the onset of apoptosis, and that this e¡ect is abolished by the
overexpression of Bcl-2. In addition, Bcl-2 overexpression re-
duces YL=G in Myc-transfected cells suggesting that a reduc-
tion in the activity or expression of LDH-A occurs in these
cells. These results are compatible with an involvement of
LDH-A in the mechanism of staurosporine-induced apopto-
sis, and that staurosporine may share a common signaling
pathway with the glucose-dependent apoptosis pathway in-
duced by Myc. The data suggest that the protective e¡ect of
Bcl-2 may be mediated via desensitization of the glucose-de-
pendent pathway either by a reduction in the activity or ex-
pression of LDH-A in the cells, and/or by abolishing the e¡ect
of staurosporine on the LPR, which in turn may enable cells
to maintain their redox state.
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